These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7564877)
21. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study. Volkow ND; Fowler JS; Logan J; Gatley SJ; Dewey SL; MacGregor RR; Schlyer DJ; Pappas N; King P; wang GJ J Nucl Med; 1995 Jul; 36(7):1289-97. PubMed ID: 7790958 [TBL] [Abstract][Full Text] [Related]
22. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377 [TBL] [Abstract][Full Text] [Related]
23. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemann R; Ding YS; Pappas N; Shea C; Piscani K Alcohol Clin Exp Res; 1996 Dec; 20(9):1594-8. PubMed ID: 8986209 [TBL] [Abstract][Full Text] [Related]
24. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Gatley SJ; Pan D; Chen R; Chaturvedi G; Ding YS Life Sci; 1996; 58(12):231-9. PubMed ID: 8786705 [TBL] [Abstract][Full Text] [Related]
25. Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine. Gatley SJ; Volkow ND; Gifford AN; Ding YS; Logan J; Wang GJ Biochem Pharmacol; 1997 Jan; 53(1):43-52. PubMed ID: 8960062 [TBL] [Abstract][Full Text] [Related]
26. [18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjects. Laakso A; Bergman J; Haaparanta M; Vilkman H; Solin O; Hietala J Synapse; 1998 Mar; 28(3):244-50. PubMed ID: 9488509 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain. Kilbourn MR; Kemmerer ES; Desmond TJ; Sherman PS; Frey KA Exp Neurol; 2004 Aug; 188(2):387-90. PubMed ID: 15246838 [TBL] [Abstract][Full Text] [Related]
28. Decreased dopamine transporters with age in health human subjects. Volkow ND; Fowler JS; Wang GJ; Logan J; Schlyer D; MacGregor R; Hitzemann R; Wolf AP Ann Neurol; 1994 Aug; 36(2):237-9. PubMed ID: 8053661 [TBL] [Abstract][Full Text] [Related]
29. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N; Nakanishi S Brain Res; 1999 Dec; 849(1-2):85-96. PubMed ID: 10592290 [TBL] [Abstract][Full Text] [Related]
30. [(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites. Fischman AJ; Bonab AA; Babich JW; Livni E; Alpert NM; Meltzer PC; Madras BK Synapse; 2001 Mar; 39(4):332-42. PubMed ID: 11169784 [TBL] [Abstract][Full Text] [Related]
31. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740 [TBL] [Abstract][Full Text] [Related]
32. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. Chen R; Han DD; Gu HH J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286 [TBL] [Abstract][Full Text] [Related]
33. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. Little KY; McLaughlin DP; Zhang L; McFinton PR; Dalack GW; Cook EH; Cassin BJ; Watson SJ Arch Gen Psychiatry; 1998 Sep; 55(9):793-9. PubMed ID: 9736005 [TBL] [Abstract][Full Text] [Related]
34. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977 [TBL] [Abstract][Full Text] [Related]
35. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Volkow ND; Fowler JS; Gatley SJ; Dewey SL; Wang GJ; Logan J; Ding YS; Franceschi D; Gifford A; Morgan A; Pappas N; King P Synapse; 1999 Jan; 31(1):59-66. PubMed ID: 10025684 [TBL] [Abstract][Full Text] [Related]
36. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis. Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633 [TBL] [Abstract][Full Text] [Related]
38. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Pan D; Gatley SJ; Dewey SL; Chen R; Alexoff DA; Ding YS; Fowler JS Eur J Pharmacol; 1994 Oct; 264(2):177-82. PubMed ID: 7851480 [TBL] [Abstract][Full Text] [Related]
39. Concentration of dopamine transporters: to Bmax or not to Bmax? Morris ED; Bonab AA; Alpert NM; Fischman AJ; Madras BK; Christian BT Synapse; 1999 May; 32(2):136-40. PubMed ID: 10231133 [No Abstract] [Full Text] [Related]
40. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain. De La Garza R; Meltzer PC; Madras BK Synapse; 1999 Oct; 34(1):20-7. PubMed ID: 10459168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]